Literature DB >> 3366121

Upstream regulatory elements are necessary and sufficient for transcription of a U6 RNA gene by RNA polymerase III.

G Das1, D Henning, D Wright, R Reddy.   

Abstract

Whereas the genes coding for trimethyl guanosine-capped snRNAs are transcribed by RNA polymerase II, the U6 RNA genes are transcribed by RNA polymerase III. In this study, we have analyzed the cis-regulatory elements involved in the transcription of a mouse U6 snRNA gene in vitro and in frog oocytes. Transcriptional analysis of mutant U6 gene constructs showed that, unlike most known cases of polymerase III transcription, intragenic sequences except the initiation nucleotide are dispensable for efficient and accurate transcription of U6 gene in vitro. Transcription of 5' deletion mutants in vitro and in frog oocytes showed that the upstream region, within 79 bp from the initiation nucleotide, contains elements necessary for U6 gene transcription. Transcription studies were carried out in frog oocytes with U6 genes containing 5' distal sequence; these studies revealed that the distal element acts as an orientation-dependent enhancer when present upstream to the gene, while it is orientation-independent but distance-dependent enhancer when placed down-stream to the U6 gene. Analysis of 3' deletion mutants showed that the transcription termination of U6 RNA is dependent on a T cluster present on the 3' end of the gene, thus providing further support to other lines of evidence that U6 genes are transcribed by RNA polymerase III. These observations suggest the involvement of a composite of components of RNA polymerase II and III transcription machineries in the transcription of U6 genes by RNA polymerase III.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366121      PMCID: PMC454347          DOI: 10.1002/j.1460-2075.1988.tb02838.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

Review 1.  Eukaryotic nuclear RNA polymerases.

Authors:  P Chambon
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  The in vitro transcription of the 7SK RNA gene by RNA polymerase III is dependent only on the presence of an upstream promoter.

Authors:  S Murphy; C Di Liegro; M Melli
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

3.  The sequence of 5 s ribosomal ribonucleic acid.

Authors:  G G Brownlee; F Sanger; B G Barrell
Journal:  J Mol Biol       Date:  1968-06-28       Impact factor: 5.469

4.  Nucleotide sequences of mouse genomic loci including a gene or pseudogene for U6 (4.8S) nuclear RNA.

Authors:  Y Ohshima; N Okada; T Tani; Y Itoh; M Itoh
Journal:  Nucleic Acids Res       Date:  1981-10-10       Impact factor: 16.971

5.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Transcriptional control regions of the adenovirus VAI RNA gene.

Authors:  D M Fowlkes; T Shenk
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

7.  A transcriptionally active pseudogene in xenopus laevis oocyte 5S DNA.

Authors:  J R Miller; D A Melton
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Nucleotide sequence of Xenopus borealis oocyte 5S DNA: comparison of sequences that flank several related eucaryotic genes.

Authors:  L J Korn; D D Brown
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

10.  Nucleotide sequences in Xenopus 5S DNA required for transcription termination.

Authors:  D F Bogenhagen; D D Brown
Journal:  Cell       Date:  1981-04       Impact factor: 41.582

View more
  93 in total

Review 1.  Survey and summary: transcription by RNA polymerases I and III.

Authors:  M R Paule; R J White
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  Effect of 3' terminal adenylic acid residue on the uridylation of human small RNAs in vitro and in frog oocytes.

Authors:  Y Chen; K Sinha; K Perumal; R Reddy
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

3.  Two internal sequence elements modulate transcription from the external human 7S K RNA gene promoter in vivo.

Authors:  B Sandrock; B J Benecke
Journal:  Gene Expr       Date:  1999

4.  Multiple, dispersed human U6 small nuclear RNA genes with varied transcriptional efficiencies.

Authors:  Angela M Domitrovich; Gary R Kunkel
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

5.  Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA.

Authors:  Frank Czauderna; Melanie Fechtner; Hüseyin Aygün; Wolfgang Arnold; Anke Klippel; Klaus Giese; Jörg Kaufmann
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

6.  An enhanced U6 promoter for synthesis of short hairpin RNA.

Authors:  Xu Gang Xia; Hongxia Zhou; Hongliu Ding; El Bashir Affar; Yang Shi; Zuoshang Xu
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

7.  Targeted cleavage of mRNA by human RNase P.

Authors:  Y Yuan; E S Hwang; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

8.  CRE recombinase-inducible RNA interference mediated by lentiviral vectors.

Authors:  Gustavo Tiscornia; Vinay Tergaonkar; Francesco Galimi; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-30       Impact factor: 11.205

9.  A role for the TATA-box-binding protein component of the transcription factor IID complex as a general RNA polymerase III transcription factor.

Authors:  R J White; S P Jackson; P W Rigby
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

10.  U4B snRNA gene enhancer activity requires functional octamer and SPH motifs.

Authors:  Z Zamrod; W E Stumph
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.